Creatine is widely recognized for its role in skeletal muscle energy metabolism, but its importance in brain function is gaining scientific attention. The brain is highly metabolically active and requires constant ATP for processes like neurotransmission and ion gradient maintenance. Creatine, through the creatine kinase system, acts as a temporal and spatial energy buffer, helping to regenerate ATP from ADP during high demand (R9). While the body synthesizes creatine endogenously and obtains it from dietary sources, brain creatine levels can be influenced by supplementation, particularly in populations with lower baseline stores or under metabolic stress (R1). Research suggests that increasing brain creatine through oral supplementation may support cognitive processing, especially in tasks relying on short-term memory and complex reasoning, where energetic demands are elevated. This rationale extends beyond muscle performance, positioning creatine as a potential nootropic agent. However, the degree to which supplementation augments brain creatine and the functional outcomes may vary based on individual factors such as diet, genetics, and age (R1, R9). Ongoing investigations aim to clarify optimal dosing strategies and contexts for cognitive enhancement.
Studies employing the standard daily dose of 5 grams of creatine have yielded mixed findings regarding cognitive enhancement, with outcomes varying across different populations. In elderly individuals, one study reported improvements in certain cognitive tasks following creatine supplementation, suggesting potential benefits in aging brains that may have lower baseline creatine levels or greater metabolic vulnerability (McMorris et al., 2007). Conversely, research in young, healthy adults found no significant cognitive improvements with the same dosing regimen, indicating that a 5-gram daily dose may not enhance brain function in populations with already adequate energy metabolism (Rawson et al., 2008). These divergent results highlight that the cognitive effects of creatine likely depend on individual factors such as age, baseline brain creatine stores, and cognitive demand. In its 2024 evaluation, the European Food Safety Authority (EFSA) concluded that a cause-and-effect relationship has not been established between creatine supplementation and improved cognitive function for the general population, reflecting the current uncertainty around the efficacy of the standard dose. This assessment, based on a review of the available evidence, underscores the need for further research to clarify the conditions under which creatine might benefit cognitive function.
Some researchers have explored higher-dose creatine strategies, such as loading protocols (20 g/day for 5–7 days) or acute high doses, under conditions that challenge brain energy metabolism, like hypoxia, sleep deprivation, or intense physical exertion. Turner et al. (2015) demonstrated that a 7-day loading protocol preserved cognitive performance during hypoxia, suggesting elevated brain creatine may buffer oxygen deprivation. Similarly, Gordji-Nejad et al. (2026) found a single high dose (~25 g) reduced sleep deprivation-induced cognitive decline, indicating acute creatine mitigates sleep loss effects. Borchio et al. (2020) reported standard loading improved cognition in mountain bikers, a context of physical and metabolic stress. While promising, these studies involve acute stress; generalizability to daily life is unclear and long-term safety data are scarce. Overall, these findings suggest that higher-dose creatine strategies may offer cognitive benefits under specific metabolic stressors, potentially by enhancing the brain's ATP buffer capacity; however, the evidence is limited to acute models and further research is needed to confirm these effects and assess long-term safety.
The overall evidence regarding creatine's cognitive-enhancing effects remains mixed, with benefits most reliably observed under conditions that challenge cerebral energy metabolism, such as sleep deprivation or hypoxia (Godwin Elechi et al., 2024). For athletes, supplementation may help maintain mental performance during fatiguing protocols (Machek & Bagley, 2018). Practical recommendations suggest that a daily dose of 5 grams is sufficient for saturating muscle creatine stores, but higher doses or loading phases (approximately 20 g/day for 5–7 days) may be necessary to rapidly increase brain creatine levels and exert cognitive effects during acute stressors. Safety considerations are generally favorable; for instance, Kastello (2015) monitored blood pressure during a creatine loading phase and found no significant cardiovascular adverse events, supporting the short-term safety of high-dose regimens. Nevertheless, individuals—particularly those with pre-existing conditions—should consult a healthcare professional before starting supplementation. Long-term safety data beyond several months remain limited, and further research is warranted to refine dosing strategies for cognitive outcomes in both athletic and general populations.